Skip to Main Content


Diseases of the Endocrine System | Genetics - Adult | Genetics - Pediatric, Phase III

VX-121 Combination Therapy in Subjects With Cystic Fibrosis VX20-121-103

What is the purpose of this trial?

The purpose of this study is to evaluate the efficacy and safety of VX-121/tezacaftor/deutivacaftor (VX-121/TEZ/D-IVA) in CF participants who are homozygous for F508del, heterozygous for F508del and a gating (F/G) or residual function (F/RF) mutation, or have at least 1 other TCR CF transmembrane conductance regulator (CFTR) gene mutation and no F508del mutation.

Contact Information

For more information about this study, including how to volunteer, contact Marie Egan

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact, or call 877.978.8343 for more information.

  • Last Updated
  • Study HIC